Skip to main content
AVNT logo

AVNT · Avient Corp

Track AVNT — free
$42.43 +1.15 (+2.79%) At close · Oct 27
Market Cap
$3.89B
Shares
91.72M
Volume · Oct 27 657.64K Avg daily vol (3M) 809.49K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$42.43 Open$41.23 Day$40.91–42.46 52W close$27.48–46.34 Avg vol 30d801K Short int4.4M · 4.8% float · 4.1d Short vol66% Last earningsNov 4, 2026 DataJan 2020–Oct 2026 Filing10-Q · Aug 6

Up next

Next earnings release
Nov 4, 2026 Announced · in 1 wks
Next earnings call
Nov 4, 2026 Scheduled · in 1 wks
call held Aug 6, 2026

Latest filings

8-K Financial results · filed Oct 9, 2026

Avient Corporation appointed Michael J. Frank as President and CEO effective October 7, 2026, succeeding Dr. Ashish K. Khandpur, who will advise through 2026; Richard H. Fearon became Non-Executive Chairman, and Avient reaffirmed third quarter and full year 2026 guidance.

Read the 8-K
10-Q filed Aug 6, 2026
Read the 10-Q
All filings

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$3.33B
Trailing 12 months
Net income (TTM)
$169.70M
Trailing 12 months
Revenue growth YoY
+5.8%
Year over year
Operating margin
9.5%
Trailing 12 months
P / E (TTM)
22.9
Trailing earnings · reciprocal yield 4.4%
FCF yield
4.9%
TTM · current market cap
Return on invested capital
6.1%
Trailing 12 months
Net cash
−$1.45B
Latest balance sheet
Dividend yield
2.6%
Trailing 12 months
Shares change YoY
+0.4%
Year over year · more shares
Price change (1Y)
+30.0%
Trailing year
Short interest
4.8%
Latest settlement · 4.1 days to cover
View all 122 metrics

AI Brief

Q2 FY26 earnings call · Aug 6, 2026
Q2 FY26

TL;DR. Avient reported Q2 adjusted EPS of $0.96, beating $0.89 guidance on stronger-than-expected organic volume, with record 18.3% adjusted EBITDA margins and 20% adjusted EPS growth, while raising full-year 2026 adjusted EPS guidance to $3.10–$3.25 (from $2.93–$3.17) and adjusted EBITDA to $575–$603M; however, transportation demand remains soft and healthcare is still weighed by customer inventory rebalancing.

Bullish
  • + Q2 adjusted EPS of $0.96 beat guidance of $0.89, driven by better-than-expected volume growth.
  • + Adjusted EBITDA margin reached a record 18.3%, expanding 110 basis points year-over-year; organic sales grew 4.3%.
  • + Full-year 2026 adjusted EPS guidance raised to $3.10–$3.25 (from $2.93–$3.17), representing 10–15% growth; adjusted EBITDA raised to $575–$603M.
  • + Asia organic sales grew 18% in Q2 with double-digit growth in both segments, driven by electronics, HPC, and functional additives.
  • + Repaid $50M of debt in Q2 ($200M over the last 12 months); 2026 free cash flow guidance raised to $210–$230M.
Bearish
  • − Transportation demand remains soft and is not expected to improve through the second half.
  • − Healthcare results are weighed down by customer inventory rebalancing in drug delivery and remote monitoring, with growth only expected to return in the second half.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Weak Quant / Vol Moderate
Market backdrop VIX 17.5 · elevated Equity put/call 0.59
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +11%
above
Price vs 50-day avg +2%
above
RSI (14) 62
neutral
MACD trend Positive
52-week position 79%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +4%
trailing
6-month return +12%
trailing
YTD return +36%
this year
Relative strength +7%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $42 › 200d $38 — 50d above 200d
Institutional flow Distributing
66 of 349 funds reported for Sep 30 · net -119.5K sh shares · +9 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
4.82% of float · ▼ -4.2% MoM · 4.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
349 holders — near 3-yr high, broad support
Squeeze score 71
high risk · 0–100
Fundamentals
Weak
Revenue growth +2%
Y/Y
Gross margin 26%
contracting
EPS growth −52%
Y/Y
Free cash flow $195.0M
Valuation P/E 22.9
in line
Balance sheet $1.4B
net debt
Quant / Vol
risk profile
Moderate
Volatility 37%
annualized · 1-yr
Max drawdown −26%
past year
ATR 3.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 2 of last 6
Latest guidance · from the Earnings Call filed Aug 6, 2026
Adjusted EBITDA · full year 2026 Non-GAAP Raised $575M – $603M
May 7, 2026 $555M – $585M changed to Aug 6, 2026 $575M – $603M
Adjusted EPS · full year 2026 Non-GAAP Raised $3.10 – $3.25
May 7, 2026 $2.93 – $3.17 changed to Aug 6, 2026 $3.10 – $3.25
Free cash flow · full year 2026 Non-GAAP $210M – $230M
Capital expenditures · full year 2026 $120M – $130M
Debt repayment · full year 2026 $100M – $150M
Total debt repayment · full year 2026 $100M – $150M
Previous outlook earlier release · from the Earnings Call filed May 7, 2026

Still-open targets the latest release did not restate under the same label.

Free cash flow · this year at least $200M
Prior guidance period ended · from the Earnings Call filed Aug 6, 2026
Adjusted EPS · third quarter $0.80
Guided vs delivered · last 6 settled
Full year sales full year
guided $3.13B
$3.14B Beat +0.4%
Sales second quarter
guided $845M
$824.4M Miss −2.4%
Sales 2022
guided $5.1B
$3.4B Miss −33.4%
Total company sales Q3
guided $1.15B
$818M Miss −28.9%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
0 · 4 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+11% Bullish
Price vs 50-day avg
+2% Bullish
RSI (14)
62 Neutral
MACD trend
Positive Bullish
52-week position
79% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $42 › 200d $38 — 50d above 200d
Institutional flow Distributing
66 of 349 funds reported for Sep 30 · net -119.5K sh shares · +9 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
4.82% of float · ▼ -4.2% MoM · 4.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
349 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $27 Now $42 · 79% Range high $46
vs 200-day avg +11% vs 50-day avg +2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA non-GAAP $318.1M Six Months Ended June 30, 2026 —
Adjusted EBITDA as a percent of sales non-GAAP 18% Six Months Ended June 30, 2026 —
Adjusted gross margin non-GAAP $593.3M Six Months Ended June 30, 2026 —
Adjusted gross margin as a percent of sales non-GAAP 33.6% Six Months Ended June 30, 2026 —
Adjusted operating income non-GAAP $226.4M Six Months Ended June 30, 2026 —
Adjusted operating income as a percent of sales non-GAAP 12.8% Six Months Ended June 30, 2026 —
Effective tax rate 26.3% the three months ended June 30, 2026 filing —
Gross margin as a percentage of sales 33.5% the three months ended June 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Specialty Chemicals — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
AVNT
Avient Corp
this stock
$3.89B +35.8% +1.7% 22.9 4.8%
LIN
Linde PLC
$234.48B +19.3% +3.0% 32.8 1.3%
AIQUF
L Air Liquide SA
$125.36B +3.0% — — 0.0%
ECL
Ecolab Inc.
$81.65B +11.0% +2.2% 39.1 1.7%
SHW
Sherwin Williams Co
$78.42B +0.6% +2.1% 29.9 2.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
356
% held
105.0%
Reported
66 of 349
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
421
View
Short & Settlement
Short Interest Falling
Shares short
4.4M
Days to cover
4.1d
Change
-193.6K sh
View
Short Volume
Short vol %
66%
As of
Oct 27, 2026
Short Total
View
Fails to Deliver
FTD shares
43
Value
$1.7K
As of
Sep 21, 2026
View
Off-Exchange
Off-exchange %
32.1%
Week of
Sep 21, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Buy
Member
Gilbert Cisneros
Amount
$1.0K–$15.0K
Traded
Mar 3, 2026
View
Financials
Financials
Revenue (FY)
$3.3B
Net income (FY)
$81.9M
EPS diluted
$0.89
View
Buybacks
Authorized
shares 20.0M
Remaining
shares 8.7M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Oct 9, 2026
This year
12

Avient Corporation appointed Michael J. Frank as President and CEO effective October 7, 2026, succeeding Dr. Ashish K. Khandpur, who will advise through 2026; Richard H. Fearon became Non-Executive Chairman, and Avient reaffirmed third quarter and full year 2026 guidance.

View
Proposed Sales
Value
$1.9M
Shares
41.4K
Filed
Aug 7, 2026
View
Earnings & Events
Webcasts Upcoming
Next webcast
Nov 4, 2026
Last webcast
Aug 6, 2026
View
Investor Relations
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
AVNT +5.2% +4.1% +12.1% +5.4% +35.8%
SPY +0.1% +0.7% +4.9% +0.9% +12.9%
vs SPY +5.1% +3.3% +7.3% +4.5% +23.0%

Capital returns

Latest dividend
$0.275 / share · ex Sep 11, 2026
Declared · upcoming
$0.2825 / share · ex Dec 11, 2026
Raised 1.9%
Paid (TTM)
$1.10 / share · 4 payouts
Dividend yield (TTM, derived)
2.59%
Full dividend history
Buyback program · as of Dec 31, 2014
Authorized
shares 20.00M
Spent (derived)
shares 11.30M
Remaining
shares 8.70M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1122976 CUSIP 05368V106 13F (30d) 71 filings 66 filers Visit website Investor relations